Profiel
Natalie Weigand was the Chief Executive Officer at PharmaSGP Holding SE from 2017 to 2025.
Prior to that, she served as the Managing Director at PharmaSGP GmbH from 2015 to 2020.
She also worked at Johnson & Johnson GmbH & Co. Wohnungsvermietung KG as a Manager-Brand & Marketing.
Ms. Weigand graduated from The National Film & Television School in 2012 with a graduate degree and from CBS Cologne Business School GmbH in 2004 with an undergraduate degree.
Eerdere bekende functies van Natalie Weigand
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARMASGP HOLDING SE | Algemeen Directeur | 01-01-2025 |
PharmaSGP GmbH
PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services Engages in developing and supplies therapies and pharmaceutical products | Algemeen Directeur | 01-05-2020 |
Johnson & Johnson GmbH & Co. Wohnungsvermietung KG
Johnson & Johnson GmbH & Co. Wohnungsvermietung KG Financial ConglomeratesFinance Provides financial services | Verkoop & Marketing | - |
Opleiding van Natalie Weigand
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
The National Film & Television School
The National Film & Television School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CBS Cologne Business School GmbH
CBS Cologne Business School GmbH Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaSGP GmbH
PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services Engages in developing and supplies therapies and pharmaceutical products | Commercial Services |
Johnson & Johnson GmbH & Co. Wohnungsvermietung KG
Johnson & Johnson GmbH & Co. Wohnungsvermietung KG Financial ConglomeratesFinance Provides financial services | Finance |
PharmaSGP Holding SE
PharmaSGP Holding SE Pharmaceuticals: MajorHealth Technology Develops non-prescription drugs and other health products | Health Technology |
















